search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
NEWS


RCP president urges PM to relax visa restrictions for overseas doctors


RCP president Professor Jane Dacre has written to the Prime Minister asking for clarification of the reason behind the veto on the relaxation of rules allowing overseas doctors to work in the NHS, and recommended excluding applications for shortage occupations from the tier 2 allocation process to help ease pressure on the NHS. Prof Dacre called for clarification of the reasoning behind this decision and also outlined the current pressures the NHS is under and highlights the need for more doctors in the NHS. The full letter is below:


Dear Prime Minister,


I am writing to you on behalf of the Royal College of Physicians to express concern about a recent report in the Evening Standard stating that calls for a relaxation of visa rules to allow overseas doctors to work in the NHS were vetoed. I would greatly welcome clarification of the reasoning behind this decision, particularly given the need for more doctors to ensure safe staffing levels for patient care.


The need for more doctors in the NHS


We are treating more patients than ever before. This increase in patient need – as people live longer, with more complex conditions – is outpacing the resources we have to care for them safely. During 2016/17, 45% of advertised consultant physician posts were not appointed to with 65% of failed appointments due to there being no suitable applicants. These posts remain vacant because of a lack of suitably trained applicants. This is having a direct impact on patient safety and the quality of patient care. A recent survey of RCP’s members and fellows found that 80% are worried about the ability of their service to deliver safe patient care in the next 12 months; 93% of respondents experienced staff shortages across the team and 85% cite rising demand for their service over the past year.


Recent announcements from the Secretary of State for Health and Social Care to increase the number of medical school places are welcome. However, given the length of time it takes to train a doctor, the NHS will need to continue to recruit doctors from overseas to meet patient need in the short-term. We therefore need to devise a system allowing the NHS to recruit enough shortage specialities, whilst also having the flexibility to bring in doctors who work in other specialities when there is a requirement.


Recommendations for action


In the short term, I am strongly urging you to make the UK more accessible and attractive to doctors from other countries. One way of doing this is keeping the current cap on restricted certificates of sponsorship for the short-term and to exclude applications for shortage occupation roles from the tier 2 allocation process.


Excluding shortage occupation applications will help ease pressure in the system now, support recruitment across the health professions to meet patient need and work for employers across all sectors in the short-term whilst the UK navigates through a complex Brexit negotiation.


In the medium term, the following policy solutions offer a pragmatic approach to


ethically increase the recruitment of overseas doctors whilst supporting the government’s position of managing migration into the UK. I am therefore calling on you to: l expand the Medical Training Initiative (MTI): the MTI offers junior doctors from Department for International Development priority countries and World Bank Low Income and Lower Middle Income (LI&LMI) Countries the opportunity to come to the UK. They work and train here before returning to their home country after two years. It is a mutually beneficial scheme; supporting the development of global healthcare services and helping trusts fill rota gaps. Its success means it is constantly oversubscribed, with candidates being held on a waiting list. We would encourage consideration of a phased increase in the current cap from 1,000 to 2,000 places.


l The RCP believes that consideration should be given to the development of a scheme like the MTI for junior doctors from non- priority countries where the RCP has strong links. These countries include Australia, where there is a surplus of Junior Doctorsi and Singapore. The use of a model like the MTI would create a mutually beneficial scheme and would meet demand from overseas colleges.


l The government should also seek to establish a scheme to attract students from particular countries to study medicine on a Tier 4 student visa in the UK


I would welcome your thoughts on the proposed policy solutions and your reasoning behind the decision to veto the relaxation of visa rules to allow overseas doctors to work in the NHS.


I look forward to you seeing your response.


Yours sincerely, Jane Dacre


Cancer campaigner uses pioneering ‘scalp cooling’ treatment some of my attention from the chemotherapy


A Cardiff man, who founded The Red Sock Campaign to help raise awareness of prostate cancer, is using a pioneering treatment to help keep his hair during chemotherapy. Over the last decade, Keith Cass has vigorously campaigned to raise awareness of prostate cancer to support men and their families living with the disease. Keith is now using the Paxman Scalp Cooler as part of his treatment at the Velindre Cancer Centre in Cardiff to help retain his hair.


“My family have always had a good head of hair even into their 80’s - my silver hair says so much about who I am and I just don’t want to lose it,” said Keith. “Scalp cooling helps divert


and gives me something else to focus on.” Hair loss is a well-known side effect of many chemotherapy regimens, with many men and women reporting it to be the most traumatic aspect of their treatment. Scalp cooling provides an alternative to hair loss, resulting in a high level of retention or even complete hair preservation, improving patients’ self-confidence and creating positive attitudes towards treatment. It works by lowering scalp temperature before, during and after the administration of chemotherapy. Liquid coolant passes through the cap extracting heat from the patient’s scalp,


12 I WWW.CLINICALSERVICESJOURNAL.COM


ensuring the scalp remains at an even, constant temperature to minimise hair loss. It is available at 95% of hospitals across the UK. Stuart Rowling, sales and training executive


at Paxman, said the company is noticing an increase in the number of men who are choosing to use scalp cooling, with some hospitals treating more men than women. “Hair loss is such as a personal thing and people, whether they are a man or a woman, will have strong reasons to why they want to keep their hair. We are noticing an increase in male scalp cooling and that’s why it is so important to raise awareness of the treatment, so men everywhere know it’s available to them.”


JUNE 2018


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80